Our findings revealed that an initial intravenous insulin infusion dose of 0.05 U/kg/h is associated with significantly lower rates of hypoglycemia and hypokalemia compared to the conventional 0.1 U/kg/h dose in pediatric DKA, with no apparent differences in reported rates of cerebral injury, mortality, hospital stay, or other adverse events. Here, INS is linked to Hypokalemia.